Anti-Addiction Vaccines: Big Profits for Drugmakers, Big Questions for Patients
![clear glass tube with white plastic tube](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/07/nlbkvkm_2cw.jpg?fit=800%2C599&ssl=1)
Martha Rosenberg In its 2016 to 2020 strategic plan, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), promoted the promise of “anti-addiction vaccines “aimed at eliciting antibodies that block the effects of a specific drug.” The quest for an anti-addiction vaccine began in earnest when Drs. Nora D. […]
Cannabis Use and Risks of Respiratory and All-cause Morbidity and Mortality: A Population-based, Data-linkage, Cohort Study
![](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/07/2152604.jpg?fit=800%2C533&ssl=1)
Nicholas T. Vozoris, Jingqin Zhu, Clodagh M. Ryan, Chung-Wai Chow, Teresa To Although cannabis is frequently used worldwide, its impact on respiratory health is characterised by controversy. … A retrospective, population-based, cohort study was carried out, linking health survey and health administrative data for residents of Ontario, Canada, aged 12–65 years, between January 2009 and […]